Diffuse malignant pleural mesothelioma, or Diffuse Mesothelioma, is a type of cancer rare but very aggressive. Is produced in the thin layer of tissue, pleura, which lines the chest cavity and the lungs. Once diagnosed with diffuse malignant pleural mesothelioma, most patients do not survive beyond one year. This cancer is more common in men than in women, and the elderly.
Diffuse malignant pleural mesothelioma
Most people DMM with a history of exposure to asbestos, but if they are aware that this exhibition was held, may be aware that they are at risk.
Diffuse mesothelioma
A patient with diffuse mesothelioma generally one or more of the following signs and symptoms: chest pain, shortness of breath, unexplained weight loss, fatigue, fever or cough. An x-ray usually shows that the tissue around the lungs pleural thickened through the development of a small number of nodes or cancerous tumors.
Diffuse malignant pleural mesothelioma
Sometimes there may be a single large growth. During a biopsy of the cancerous tissue is made, the types of cells that compose the cancer can be epithelia, sarcomata or mixed. People with epithelial cell cancers tend to survive a little longer, those sarcomata cancers usually have lower survival.
Diffuse malignant mesothelioma
Diffuse mesothelioma is always treated as aggressively as possible. The type of treatment depends on the type
Diffuse mesothelioma
Surgery is a preferred choice in most of the tumor can be removed. Many cancer drugs are considered to treat DMM, with varying levels of success in the short term.
Diffuse mesothelioma
Radiation therapy may also be an option. Several clinical trials are ongoing to try to find a treatment that could improve the prognosis of patients diffuse mesothelioma. However, only seven percent of people with DMM survive beyond five years.
0 comments:
Post a Comment